Fig. 4.
Change in % predicted MIP at week 72. Individual subject change from baseline after receiving 20 mg/kg reveglucosidase alfa intravenously every 2 weeks. Abbreviation: MIP, maximal inspiratory pressure
Change in % predicted MIP at week 72. Individual subject change from baseline after receiving 20 mg/kg reveglucosidase alfa intravenously every 2 weeks. Abbreviation: MIP, maximal inspiratory pressure